Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended that Keytruda's coming loss of ...

The current approach to global vaccine research and development (R&D), manufacturing, and distribution has greatly expanded routine immunisation, achieving substantial reductions in disease burden ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.